HK1032262A1 - Prognostic allergy or inflammation test. - Google Patents

Prognostic allergy or inflammation test.

Info

Publication number
HK1032262A1
HK1032262A1 HK01102652A HK01102652A HK1032262A1 HK 1032262 A1 HK1032262 A1 HK 1032262A1 HK 01102652 A HK01102652 A HK 01102652A HK 01102652 A HK01102652 A HK 01102652A HK 1032262 A1 HK1032262 A1 HK 1032262A1
Authority
HK
Hong Kong
Prior art keywords
antibodies
antigen
child
allergy
peptides
Prior art date
Application number
HK01102652A
Other languages
English (en)
Inventor
Hugh A Sampson
Original Assignee
Seer Pharmaceuticals Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Seer Pharmaceuticals Llc filed Critical Seer Pharmaceuticals Llc
Publication of HK1032262A1 publication Critical patent/HK1032262A1/xx

Links

Classifications

    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5091Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing the pathological state of an organism
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803General methods of protein analysis not limited to specific proteins or families of proteins
    • G01N33/6842Proteomic analysis of subsets of protein mixtures with reduced complexity, e.g. membrane proteins, phosphoproteins, organelle proteins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6878Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids in eptitope analysis
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/02Nutritional disorders
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00Detection or diagnosis of diseases
    • G01N2800/24Immunology or allergic disorders

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Physics & Mathematics (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Physiology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Plant Substances (AREA)
HK01102652A 1998-01-30 2001-04-12 Prognostic allergy or inflammation test. HK1032262A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US7317198P 1998-01-30 1998-01-30
PCT/US1999/001832 WO1999039211A1 (en) 1998-01-30 1999-01-28 Prognostic allergy or inflammation test

Publications (1)

Publication Number Publication Date
HK1032262A1 true HK1032262A1 (en) 2001-07-13

Family

ID=22112157

Family Applications (2)

Application Number Title Priority Date Filing Date
HK01102652A HK1032262A1 (en) 1998-01-30 2001-04-12 Prognostic allergy or inflammation test.
HK08114114.4A HK1120865A1 (en) 1998-01-30 2008-12-31 Prognostic allergy test

Family Applications After (1)

Application Number Title Priority Date Filing Date
HK08114114.4A HK1120865A1 (en) 1998-01-30 2008-12-31 Prognostic allergy test

Country Status (10)

Country Link
US (1) US6238925B1 (ja)
EP (2) EP1939628B1 (ja)
JP (1) JP4292262B2 (ja)
AT (2) ATE426170T1 (ja)
AU (1) AU741635B2 (ja)
CA (1) CA2319317C (ja)
DE (1) DE69919327D1 (ja)
ES (2) ES2383002T3 (ja)
HK (2) HK1032262A1 (ja)
WO (1) WO1999039211A1 (ja)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10110838C2 (de) * 2001-03-06 2003-04-03 Mlu Halle Wittenberg Verfahren zur Diagnostik von Allergien, Pseudoallergien und Intoleranzen
EP1410037A2 (de) * 2001-03-10 2004-04-21 Affina Immuntechnik GmbH Verfahren zur identifikation von immunreaktiven epitopen auf proteinen und verwendung der epitope zu prophylaktischen und therapeutischen zwecken
AU2004232362C1 (en) * 2003-04-23 2008-05-29 E. R. Squibb & Sons, L.L.C. Compositions and methods for the therapy of inflammatory bowel disease
PL2662390T3 (pl) 2004-06-21 2017-12-29 E. R. Squibb & Sons, L.L.C. Antyciała receptora interferonu alfa I oraz ich zastosowania
US8859210B2 (en) * 2008-10-17 2014-10-14 Mead Johnson Nutrition Company Method for identifying allergenic proteins and peptides
CN102341705B (zh) * 2009-03-05 2015-08-19 味之素株式会社 克罗恩氏病诊断试剂
WO2011032097A1 (en) * 2009-09-14 2011-03-17 Mount Sinai School Of Medicine Methods for characterizing antibody binding affinity and epitope diversity in food allergy
WO2012135313A1 (en) * 2011-03-28 2012-10-04 University Of Massachusetts Compositions and methods for detecting allergy to a-gal epitopes
US9597385B2 (en) 2012-04-23 2017-03-21 Allertein Therapeutics, Llc Nanoparticles for treatment of allergy
SG11201508113SA (en) 2013-04-03 2015-10-29 Allertein Therapeutics Llc Novel nanoparticle compositions
KR102202575B1 (ko) 2013-12-31 2021-01-13 삼성전자주식회사 메모리 관리 방법 및 장치
ES2899191T3 (es) * 2014-04-03 2022-03-10 AllerGenis LLC Péptidos y procedimientos de detección de alergia alimentaria
CA3145879A1 (en) 2014-11-14 2016-05-19 Biomerica, Inc. Compositions, devices, and methods of ibs sensitivity testing
EP3173789A1 (en) * 2015-11-24 2017-05-31 Helmholtz-Zentrum für Infektionsforschung GmbH Method for differentiation of immune response in an individual
JP2019515275A (ja) * 2016-04-26 2019-06-06 バイオメリカ・インコーポレイテッドBiomerica, Inc. 潰瘍性大腸炎感受性試験の組成物、デバイスおよび方法
JP7062291B2 (ja) * 2016-05-13 2022-05-16 応用酵素医学研究所株式会社 アレルギー発症リスクを予測するためのデータを収集する方法
RU2621312C1 (ru) * 2016-06-15 2017-06-01 Федеральное государственное автономное учреждение "Научный центр здоровья детей" Министерства здравоохранения Российской Федерации (ФГАУ "НЦЗД" Минздрава России) Способ прогнозирования формирования толерантности при аллергии к белку коровьего молока у детей раннего возраста
EP3474013A4 (en) * 2016-06-16 2020-02-26 Hoyu Co., Ltd. FISH ALLERGY ANTIGEN
CN110716055A (zh) * 2019-09-11 2020-01-21 天津医科大学 过敏原特异性免疫球蛋白e致病活性检测试剂盒
CN116249899A (zh) * 2020-09-07 2023-06-09 三菱瓦斯化学株式会社 过敏性疾病的判定方法和判定系统

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5736362A (en) * 1990-10-26 1998-04-07 The University Of Melbourne Ryegrass pollen allergen
US5567594A (en) * 1991-04-26 1996-10-22 Enteron, L.P. Methods and compositions for the detection and treatment of diseases associated with antigens of microorganisms
US5480972A (en) * 1992-10-30 1996-01-02 The University Of Melbourne Allergenic proteins from Johnson grass pollen
US5558869A (en) * 1992-12-30 1996-09-24 University Of Arkansas Major peanut allergen ara h II
CA2152818A1 (en) * 1992-12-31 1994-07-21 Jay P. Morgenstern Allergenic proteins and peptides from dog dander and uses therefor

Also Published As

Publication number Publication date
ATE550665T1 (de) 2012-04-15
EP1051626A1 (en) 2000-11-15
US6238925B1 (en) 2001-05-29
CA2319317A1 (en) 1999-08-05
EP1051626B1 (en) 2009-03-18
JP4292262B2 (ja) 2009-07-08
AU741635B2 (en) 2001-12-06
DE69919327T2 (de) 2005-03-10
EP1939628A1 (en) 2008-07-02
AU2347899A (en) 1999-08-16
WO1999039211A1 (en) 1999-08-05
ES2383002T3 (es) 2012-06-15
JP2002502039A (ja) 2002-01-22
DE69919327D1 (de) 2009-11-26
ES2229673T3 (es) 2009-08-04
ATE426170T1 (de) 2009-04-15
CA2319317C (en) 2006-04-18
HK1120865A1 (en) 2009-04-09
EP1939628B1 (en) 2012-03-21

Similar Documents

Publication Publication Date Title
HK1120865A1 (en) Prognostic allergy test
RU2004136285A (ru) Способ диагностики гепатоцеллюлярной карциномы
Churchman et al. Multiplexing immunoassays for cytokine detection in the serum of patients with rheumatoid arthritis: lack of sensitivity and interference by rheumatoid factor
ATE126594T1 (de) Verfahren zur herstellung des hochmolekulargewichtigen zell-verbundenen proteins von campylobakter pylori und seine verwendung zum serologischen nachweis von campylobakter pylori-infektionen.
DE69531311D1 (de) Monoklonale antikörper spezifisch für endprodukte der fortgeschrittenen glycosylation in biologischen proben
DE60333471D1 (de) Polyklonaler-monoklonaler-elisa-assay zum nachweis von n-terminalem probnp
DK0378175T3 (da) Diagnostisk påvisning under anvendelse af kimære antistoffer
ATE121788T1 (de) Blutgerinnungsfaktor beta xiia monoklonale antikörper und immunanalyse.
DE69112225T2 (de) Immunodiagnostische probe für gelenkrheumatismus.
DE602005025559D1 (de) Diagnostischer Test für menschliches matrix Gla-Protein und seine Verwendung als Biomarker
ATE282830T1 (de) Immuntest für human chromogranine a (cga), antikörper, reagenz und dazu geeigneter testsatz
JPH10507266A (ja) 体液中のコラーゲンの断片化パターンの評価とコラーゲンの代謝に関連する疾患の診断
DK0747481T3 (da) Epstein-Barr-viruspeptider og antistoffer mod disse peptider
NO913037L (no) Peptider med for alfal-mikroglobulin karakteristiske antigene determinanter.
Phillips et al. Quantitative characterization of specificity and potency of conjugated antibody with solid-phase, antigen bead standards
DE60037115D1 (de) Diagnostischer test für menschlisches matrix gla-protein und seine verwendung als biomarker
WO1998047922A3 (en) Determination of recombinant glycosylated proteins and peptides in biological fluids
KR870002453A (ko) 프로좀 단백질에 대한 단일항체의 제조방법 및 그를 이용한 프로좀과 관련된 현상의 검출 및 질병의 진단법
ATE184286T1 (de) Hgpiib-fragmente und ihre verwendung in in-vitro- verfahren zur bestimmung von in vivo stattfindenden thrombotischen ereignissen
ATE249043T1 (de) Immunoassay und kit für iga antikörper, spezifisch für acetaldehyd-addukte
ATE389175T1 (de) Verfahren zur prüfung von antigenen, die mit durch mentalen stress bedingten erkrankungen assoziiert sind
EP0368674A3 (en) Immunoassay and test kits therefor
Sheng et al. Electroimmunoblotting of myelin basic protein peptides: a novel approach to the rapid characterisation of antigenic specificities of monoclonal and polyclonal anti-MBP antibodies
WO1994002507A3 (en) Methods for detecting pre-clinical iddm
SE9601231D0 (sv) Monoclonal antibody

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140128